Can I Take Glutathione with Trazodone?

What trazodone is and how it is broken down

Trazodone is an FDA-approved serotonin antagonist and reuptake inhibitor (SARI) used for major depressive disorder. It also blocks histamine H1 and alpha-1 adrenergic receptors, which is why it causes sedation and why clinicians frequently prescribe it off-label, at much lower doses, for insomnia.

The liver clears trazodone largely through the cytochrome P450 enzyme CYP3A4, producing an active metabolite (meta-chlorophenylpiperazine, or mCPP) that has its own serotonergic activity. Drugs that strongly inhibit CYP3A4, such as certain antifungals, protease inhibitors, or large amounts of grapefruit juice, can raise trazodone blood levels and increase sedation, low blood pressure, and, rarely, serotonin syndrome. This is the pathway to check whenever a new supplement is added: does it change CYP3A4 activity?

Common trazodone side effects include sedation, dizziness, dry mouth, and orthostatic hypotension. Rare but serious risks include priapism and dose-related QT prolongation. Trazodone-associated liver injury is described in the medical literature as uncommon; readers with a personal history of liver disease or unexplained abnormal liver tests should raise this specifically with their prescriber rather than relying on population-level reassurance.

What glutathione is and how people take it

Glutathione (gamma-L-glutamyl-L-cysteinylglycine) is a small protein made naturally in every human cell and concentrated in the liver, where it helps neutralize reactive byproducts of drug metabolism. As a supplement it is sold in several forms:

• Oral reduced glutathione: commonly dosed around 250-500 mg/day in the clinical studies available.
• Liposomal oral glutathione: marketed for higher absorption; doses are similar, roughly 200-500 mg/day.
• Sublingual glutathione: less studied than oral or IV forms.
• Intravenous (IV) glutathione: given in clinic settings at doses from roughly 600 mg to over 2,000 mg per session, bypassing the gut entirely and producing much higher, though transient, plasma levels than any oral dose.

Oral glutathione is partly broken down in the gut and liver before it reaches systemic circulation, so a meaningful amount taken by mouth does not translate one-to-one into blood levels. Small trials of oral and liposomal glutathione have reported measurable increases in whole-blood glutathione over several weeks, but exact effect sizes vary by formulation and study design; a reader relying on a specific percentage increase should ask their pharmacist or physician to check the primary study rather than take a single number as settled fact.

Does glutathione interact with trazodone?

The short answer: no drug interaction database or published case report available to us documents a clinically meaningful interaction between glutathione and trazodone. That absence of evidence is reassuring but not the same as a controlled study proving safety in combination, because this specific pairing has not been a research priority.

The pharmacokinetic question

An interaction at the level of drug clearance would require glutathione, or something it produces, to meaningfully inhibit or induce CYP3A4. Glutathione's best-established biochemical role is in phase II conjugation reactions (via glutathione-S-transferase enzymes), which is a separate detoxification system from the phase I cytochrome P450 oxidation that clears trazodone. Boosting glutathione stores may support phase II throughput generally, but that is a different pathway from the one that determines how quickly trazodone leaves the body. We could not confirm, from the sources available for this article, a controlled human study measuring glutathione's direct effect on CYP3A4 activity; if a reader needs that specific number for a clinical decision, it should be verified against the primary pharmacology literature rather than taken from a secondary summary.

The pharmacodynamic question

A pharmacodynamic interaction would require both compounds to act on the same receptor system. Trazodone's relevant targets are serotonin transporters, 5-HT2A receptors, histamine H1 receptors, and alpha-1 adrenergic receptors. Glutathione has no established direct activity at any of these. Its recognized roles are antioxidant buffering and support of redox-dependent immune signaling. There is no known mechanism by which standard-dose glutathione would add to trazodone's sedation or change its antidepressant effect.

The IV glutathione exception

Intravenous glutathione delivers a much larger, faster dose than any oral product and has received far less safety research generally, let alone in combination with specific psychiatric medications. No published case report of a trazodone-IV glutathione adverse event was located for this article, but that absence likely reflects how little this specific combination has been studied, not a demonstrated safety record. Anyone using or considering IV glutathione infusions (for skin, wellness, or other reasons) while taking trazodone should disclose the medication to both the infusion provider and the prescribing physician, the same way they would disclose it before starting any new prescription drug.

Where trazodone and glutathione both touch the liver

Both compounds are relevant to hepatic function, though through different mechanisms, and this is the most clinically meaningful area of overlap.

Trazodone-related liver injury is rare but has been described in the psychiatric and hepatology literature, generally attributed to reactive metabolites formed during CYP3A4 processing. Patients with pre-existing elevated liver enzymes or known liver disease carry a higher baseline risk for drug-induced liver injury generally, independent of any supplement.

Glutathione and its precursors are used clinically in some contexts to support liver function. N-acetylcysteine, the best-studied glutathione precursor, is a standard treatment for acetaminophen overdose because it replenishes hepatic glutathione stores; that established use does not automatically transfer to a claim about protecting the liver during trazodone use, which has not been directly tested in trials. Small trials of oral glutathione in fatty liver disease have reported improvements in liver enzyme markers, but sample sizes have generally been small, and this evidence base has not been extended to trazodone users specifically. The plausible, not proven, inference is that adequate glutathione status is unlikely to worsen trazodone's hepatic handling and could theoretically be supportive in someone at elevated risk for liver strain, but this remains an extrapolation rather than a demonstrated finding.

Evidence-status assessment: glutathione plus trazodone

What a clinician or pharmacist should verify before advising a patient: current liver enzyme values if the patient has any liver history, the full supplement and medication list for other CYP3A4 inhibitors or inducers, the specific glutathione formulation and dose (oral versus IV), and whether the patient has any personal or family history of serotonin syndrome risk factors.

Medications and substances that do interact with trazodone

Context matters. Trazodone has clearly documented interactions with other substances, which helps explain why glutathione is treated differently.

• Strong CYP3A4 inhibitors: certain azole antifungals, some HIV protease inhibitors, clarithromycin, and large quantities of grapefruit juice can raise trazodone blood levels and increase sedation and adverse effects. This is described in trazodone's FDA prescribing information.
• Serotonergic drugs: MAOIs, linezolid, and tramadol carry a labeled risk of serotonin syndrome when combined with trazodone.
• CNS depressants: alcohol, benzodiazepines, and opioids add to trazodone's sedative effect.
• St. John's Wort: a strong CYP3A4 inducer that can lower trazodone levels and is generally considered a combination to avoid without medical supervision.

Glutathione does not fall into any of these categories based on the evidence reviewed here.

Monitoring if you take both

• Before starting glutathione at meaningful doses, a baseline comprehensive metabolic panel (AST, ALT, alkaline phosphatase, bilirubin) is reasonable, especially if you have any liver history.
• A follow-up liver panel some weeks after starting is a reasonable check-in point to discuss with your prescriber; there is no single validated interval specific to this combination, so let your clinician set the schedule based on your individual risk.
• For IV glutathione, ask the infusing clinic and your prescribing physician to coordinate on monitoring frequency, since this route delivers a much larger dose than oral supplementation.
• Contact your doctor promptly for jaundice, right upper quadrant pain, dark urine, pale stools, or unexplained fatigue or nausea after starting any new supplement. These are general warning signs of liver stress and are not specific to this combination, but they always warrant evaluation.

Evidence boundary: what is established, what is not

Established: trazodone is FDA-approved for major depressive disorder and metabolized mainly by CYP3A4; strong CYP3A4 inhibitors and serotonergic drugs are documented interaction risks for trazodone; glutathione's core biochemical role is phase II detoxification and antioxidant buffering, a separate system from CYP3A4-mediated clearance.

Plausible but unproven: that glutathione supplementation offers any protective benefit specifically for people on trazodone; that IV glutathione is safe to combine with trazodone at any dose; that glutathione measurably changes trazodone blood levels in either direction.

Not established: any pharmacokinetic or pharmacodynamic mechanism by which standard-dose oral glutathione would meaningfully interact with trazodone. Readers should treat the absence of reported interactions as reassuring rather than as proof of safety in every individual, particularly for IV use, since this specific combination has not been a focus of controlled research.

This is general information, not individualized medical advice. It does not replace a conversation with your prescriber or pharmacist about your specific health history, current medications, and liver function.